Safe use of 125I-fibrinogen.
D000328:Adult; D000368:Aged; D001782:Blood Donors; D002986:Clinical Trials as Topic; D005260:Female; D005340:Fibrinogen / Q000008:administration & dosage / Q000009:adverse effects; D005500:Follow-Up Studies; D006506:Hepatitis A / Q000276:immunology / Q000517:prevention & control; D006509:Hepatitis B / Q000517:prevention & control*; D006801:Humans; D007267:Injections; D007457:Iodine Radioisotopes; D008297:Male; D008722:Methods; D008875:Middle Aged; D011183:Postoperative Complications; D011863:Radioimmunoassay; D013514:Surgical Procedures, Operative; D011795:Surveys and Questionnaires; D013924:Thrombophlebitis / Q000175:diagnosis* / Q000209:etiology
D007457:Iodine Radioisotopes; D005340:Fibrinogen